Scientists may have found anti-aging mushrooms that can delay signs of aging, but more research is needed to make eating them feasible.
In recent years, there has been a significant rise in the interest and acceptance of psilocybin mushrooms across Canada.
UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.